Search results
Repeat COVID Vaccination Could Shield Against Wide Range of Viruses
WFMZ Eastern Pennsylvania and Western New Jersey· 4 days agoPowerful COVID vaccines could be setting people’s immune systems up to successfully fight off not...
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
Medical Xpress· 7 days agoThe COVID-19 pandemic is over, but the virus that caused it is still here, sending thousands of...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 8 hours agoJohnson & Johnson’s radiopharmaceutical spurred “profound and durable” responses, however, four...
Could FLiRT Variants Cause Another Covid-19 Surge?
Forbes· 4 days agoA new Covid-19 variant known as KP.2, or FLiRT, began to emerge in the United States in early March of this year. This dramatic rise signals that KP.2...
Earnings call: Dyadic International Eyes Growth in Health and Proteins By Investing.com
Investing.com· 6 days agoDyadic International has made notable progress in the human health sector, particularly with its ...
Cows in the US have bird flu - is it inching closer to humans?
BBC via Yahoo News· 3 days agoA little over half of those cases have resulted in death but many more cases will have gone...
Does COVID-19 Persist?
MedPage Today· 5 days agoWith 17 million adults reporting long COVID symptoms like brain fog and fatigue, the idea of viral persistence has gained traction. "At the beginning of...
Urine Tests Could Be 'Enormous Step' in Diagnosing Cancer
Medscape· 4 days agoThe next frontier in cancer detection could be the humble urine test. Emerging science suggests that...
Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...
FOX 59 Indianapolis· 9 hours agoMabwell (688062.SH), an innovation-driven biopharmaceutical company, announced the data and latest...
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
The Kansas City Star· 2 days agoSHELTON, CT / ACCESSWIRE / May 23, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports that it ...